Belinostat Resolves Skin Barrier Defects in Atopic Dermatitis by Targeting the Dysregulated miR-335:SOX6 Axis
Journal of Allergy and Clinical Immunology - United States
doi 10.1016/j.jaci.2020.02.007
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2020
Authors
Publisher
Elsevier BV